FENNEC PHARMACEUTICALS INC's ticker is and the CUSIP is 31447P900. A total of 3 filers reported holding FENNEC PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1 | -91.7% | 300 | -72.7% | 0.00% | – |
Q1 2024 | $12 | +500.0% | 1,100 | +450.0% | 0.00% | – |
Q4 2023 | $2 | -98.6% | 200 | -98.9% | 0.00% | – |
Q3 2023 | $141 | +17.5% | 18,900 | +38.0% | 0.00% | – |
Q2 2023 | $120 | -26.4% | 13,700 | -30.1% | 0.00% | – |
Q1 2023 | $163 | +44.2% | 19,600 | +66.1% | 0.00% | – |
Q4 2022 | $113 | -99.9% | 11,800 | +8.3% | 0.00% | – |
Q3 2022 | $88,000 | +8700.0% | 10,900 | +3533.3% | 0.00% | – |
Q2 2022 | $1,000 | -87.5% | 300 | -81.2% | 0.00% | – |
Q1 2022 | $8,000 | -69.2% | 1,600 | -73.3% | 0.00% | – |
Q4 2021 | $26,000 | – | 6,000 | +5900.0% | 0.00% | – |
Q3 2021 | $0 | – | 100 | 0.0% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 100 | +614.3% | 0.00% | – |
Q4 2020 | $10,000 | -85.9% | 14 | -83.7% | 0.00% | – |
Q2 2020 | $71,000 | +36.5% | 86 | -3.4% | 0.00% | – |
Q1 2020 | $52,000 | – | 89 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
SIMPLEX TRADING, LLC | 6,000 | $26,000 | 0.00% |
GROUP ONE TRADING, L.P. | 500 | $2,000 | 0.00% |